Literature DB >> 1851059

Wilms' tumour: pre- and post-chemotherapy CT appearances.

Y Y Ng1, M A Hall-Craggs, C Dicks-Mireaux, J Pritchard.   

Abstract

Pre-operative chemotherapy is used in our institution for patients with Wilms' Tumours (WT) when surgical 'operability' is in doubt. To date, the computed tomographic (CT) appearances of chemotherapy-induced changes in WT have not been described. We have analysed CT examinations of 18 children undergoing pre-operative chemotherapy to assess the effects of treatment on size, extent and qualitative changes of the tumour. Clinical response to chemotherapy was associated with a reduction in tumour size of at least 50%. Cystic changes were commonly seen within tumours following chemotherapy. CT did not reliably differentiate lymph nodes involved by tumour from those showing only reactive change. Pre-chemotherapy CT scans were incorrect in predicting liver invasion in 4/18 (22%) cases: of these, two were right-sided tumours, and two were bilateral.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1851059     DOI: 10.1016/s0009-9260(05)80250-8

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  3 in total

1.  Management and outcome of inoperable Wilms tumor. A report of National Wilms Tumor Study-3.

Authors:  M L Ritchey; K C Pringle; N E Breslow; J Takashima; J Moksness; C W Zuppan; J B Beckwith; P R Thomas; P P Kelalis
Journal:  Ann Surg       Date:  1994-11       Impact factor: 12.969

2.  Changes in computed tomography features following preoperative chemotherapy for nephroblastoma: relation to histopathological classification.

Authors:  Øystein E Olsen; Annmarie C Jeanes; Neil J Sebire; Derek J Roebuck; Anthony J Michalski; Rupert A Risdon; Catherine M Owens
Journal:  Eur Radiol       Date:  2004-02-11       Impact factor: 5.315

Review 3.  Wilms tumour: diagnosis and treatment.

Authors:  M J Coppes; J E Wolff; M L Ritchey
Journal:  Paediatr Drugs       Date:  1999 Oct-Dec       Impact factor: 3.930

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.